Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
Authors
Keywords
-
Journal
TRANSPLANT INTERNATIONAL
Volume 31, Issue 4, Pages 451-455
Publisher
Wiley
Online
2018-01-12
DOI
10.1111/tri.13111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients
- (2017) Olivier Aubert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis
- (2017) Clément Gosset et al. KIDNEY INTERNATIONAL
- Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
- (2017) Marc-Antoine Béland et al. TRANSPLANT INTERNATIONAL
- Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
- (2016) S. Kulkarni et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations
- (2016) M. Haas AMERICAN JOURNAL OF TRANSPLANTATION
- Potential Roles for C1 Inhibitor in Transplantation
- (2016) Mel Berger et al. TRANSPLANTATION
- One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation
- (2016) Bénédicte Sautenet et al. TRANSPLANTATION
- Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures
- (2015) Jelle de Wit et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- (2014) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B cells mediate chronic allograft rejection independently of antibody production
- (2014) Qiang Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Late Antibody-Mediated Rejection in Renal Allografts
- (2014) Gaurav Gupta et al. TRANSPLANTATION
- Rituximab in renal transplantation
- (2013) A. Nicholas R. Barnett et al. TRANSPLANT INTERNATIONAL
- Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
- (2011) N. Kohei et al. AMERICAN JOURNAL OF TRANSPLANTATION
- IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro
- (2010) Jean-David Bouaziz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
- (2010) Alexandre Loupy et al. TRANSPLANTATION
- A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation
- (2008) V. Zarkhin et al. AMERICAN JOURNAL OF TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started